Cargando…

Dipeptidyl Peptidase-4 Inhibitors Cause Bullous Pemphigoid in Diabetic Patients: Report of Two Cases

Detalles Bibliográficos
Autores principales:	Pasmatzi, Efi, Monastirli, Alexandra, Habeos, John, Georgiou, Sophia, Tsambaos, Dionysios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Diabetes Care Electronic Pages
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142019/ https://www.ncbi.nlm.nih.gov/pubmed/21788636 http://dx.doi.org/10.2337/dc11-0804

Ejemplares similares

RS3PE in Association With Dipeptidyl Peptidase-4 Inhibitor: Report of Two Cases
por: Yamauchi, Keishi, et al.
Publicado: (2012)

Comment on: Monami et al. Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures: A Meta-analysis of Randomized Clinical Trials. Diabetes Care 2011;34:2474–2476
por: Yamagishi, Sho-ichi
Publicado: (2012)

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
por: Tasanen, Kaisa, et al.
Publicado: (2019)

Bullous pemphigoid associated with use of dipeptidyl peptidase-4 inhibitor
por: Kano, Yasuhiro, et al.
Publicado: (2022)

Galectin 3: an extraordinary multifunctional protein in dermatology. Current knowledge and perspectives
por: Pasmatzi, Efstathia, et al.
Publicado: (2019)

Bullous pemphigoid with dipeptidyl peptidase‐4 inhibitors: Clinical features and pathophysiology
por: Murakami, Takaaki, et al.
Publicado: (2019)

Co-medications and dipeptidyl peptidase-4 inhibitors associated bullous pemphigoid()()
por: Gravani, Agoritsa, et al.
Publicado: (2021)

Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor – A case report
por: Karthik, S, et al.
Publicado: (2019)

Multiple Large and Dome-Shaped Nodules on the Lower Extremity
por: Pasmatzi, Efstathia, et al.
Publicado: (2022)

Bullous pemphigoid associated with dipeptidyl peptidase‐4 inhibitors: A report of five cases
por: Yoshiji, Satoshi, et al.
Publicado: (2017)

Diabetic Ketosis Caused by the Insulin Analog Aspart–Induced Anti-Insulin Antibody: Successful Treatment With the Newest Insulin Analog Glulisine
por: Yanai, Hidekatsu, et al.
Publicado: (2011)

Comment on: Wehr et al. Low Free Testosterone Levels Are Associated With All-Cause and Cardiovascular Mortality in Postmenopausal Diabetic Women. Diabetes Care 2011;34:1771–1777
por: Kuhadiya, Nitesh D., et al.
Publicado: (2012)

Response to Comment on: Wehr et al. Low Free Testosterone Levels Are Associated With All-Cause and Cardiovascular Mortality in Postmenopausal Diabetic Women. Diabetes Care 2011;34:1771–1777
por: Lerchbaum, Elisabeth, et al.
Publicado: (2012)

Clinical, Laboratory and Histological Features of Dipeptidyl Peptidase-4 Inhibitor Related Noninflammatory Bullous Pemphigoid
por: Kinyó, Ágnes, et al.
Publicado: (2021)

The association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors: a ten-year prospective observational study
por: Lambadiari, Vaia, et al.
Publicado: (2021)

Dipeptidyl Peptidase-4 Inhibitor-Related Bullous Pemphigoid: Clinical, Laboratory, and Histological Features, and Possible Pathogenesis
por: Hung, Chih-Tsung, et al.
Publicado: (2022)

Dipeptidyl-Peptidase 4 Inhibitor-Induced Variants of Bullous Pemphigoid: A Case Series of Four Patients
por: Balighi, Kamran, et al.
Publicado: (2022)

Lisinopril prevents bullous pemphigoid induced by dipeptidyl peptidase 4 inhibitors via the Mas receptor pathway
por: Nozawa, Keisuke, et al.
Publicado: (2023)

Comment on: Lipsky and Berendt. Hyperbaric Oxygen Therapy for Diabetic Foot Wounds: Has Hope Hurdled Hype? Diabetes Care 2010;33:1143–1145
por: van der Staal, Sebastiaan R., et al.
Publicado: (2011)

Increasing the Low-Glucose Alarm of a Continuous Glucose Monitoring System Prevents Exercise-Induced Hypoglycemia Without Triggering Any False Alarms
por: Iscoe, Katherine E., et al.
Publicado: (2011)

Response to comment on: Löndahl et al. Hyperbaric Oxygen Therapy Facilitates Healing of Chronic Foot Ulcers in Patients With Diabetes. Diabetes Care 2010;33:998–1003
por: Löndahl, Magnus, et al.
Publicado: (2011)

Insulin Concerns and Promises
por: Bloomgarden, Zachary T.
Publicado: (2011)

Response to Comment on: Lipsky and Berendt. Hyperbaric Oxygen Therapy for Diabetic Foot Wounds: Has Hope Hurdled Hype? Diabetes Care 2010;33:1143–1145
por: Lipsky, Benjamin A.
Publicado: (2011)

Diabetic Ketoacidosis Complicated With Previously Unknown Gitelman Syndrome in a Tunisian Child
por: Biagioni, Martina, et al.
Publicado: (2011)

Comment on: Olsson et al. High Levels of Education Are Associated With an Increased Risk of Latent Autoimmune Diabetes in Adults: Results From the Nord-Trøndelag Health Study. Diabetes Care 2011;34:102–107
por: Sawicki, Peter T., et al.
Publicado: (2011)

Response to Comment on: Olsson et al. High Levels of Education Are Associated With an Increased Risk of Latent Autoimmune Diabetes in Adults: Results From the Nord-Trøndelag Health Study. Diabetes Care 2011;34:102–107
por: Olsson, Lisa, et al.
Publicado: (2011)

Comment on: Polonsky et al. Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes: Results From the Structured Testing Program Study. Diabetes Care 2011;34:262–267
por: Stephens, Jeffrey W., et al.
Publicado: (2011)

Nonnutritive Sweeteners, Fructose, and Other Aspects of Diet
por: Bloomgarden, Zachary T.
Publicado: (2011)

Hypoglycemia in Patients With Diabetes on Antidiabetic Medications Who Fast for Laboratory Tests
por: Aldasouqi, Saleh, et al.
Publicado: (2011)

Response to Comment on: Boronat et al. Differences in Cardiovascular Risk Profile of Diabetic Subjects Discordantly Classified by Diagnostic Criteria Based on Glycated Hemoglobin and Oral Glucose Tolerance Test. Diabetes Care 2010;33:2671–2673
por: Boronat, Mauro, et al.
Publicado: (2011)

Response to Comment on: Polonsky et al. Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes: Results From the Structured Testing Program Study. Diabetes Care 2011;34:262–267
por: Polonsky, William H., et al.
Publicado: (2011)

Comment on: Sun et al. Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration: The Joslin 50-Year Medalist Study. Diabetes Care 2011;34:968–974
por: Conway, Baqiyyah N., et al.
Publicado: (2011)

World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease: Part 3
por: Bloomgarden, Zachary T.
Publicado: (2011)

Insulin Autoimmune Syndrome Induced by α–Lipoic Acid in a Caucasian Woman: Case Report
por: Bresciani, Enrico, et al.
Publicado: (2011)

Comment on: Gaillard et al. HDL Dysfunctionality (Paraoxonase) Is Worse in Nondiabetic, Postmenopausal African American Than in White Women. Diabetes Care 2011;34:e19
por: Viktorinova, Alena, et al.
Publicado: (2011)

Response to Comment on: Sun et al. Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration: The Joslin 50-Year Medalist Study. Diabetes Care 2011;34:968–974
por: Sun, Jennifer K., et al.
Publicado: (2011)

Response to Comment on: Gaillard et al. HDL Dysfunctionality (Paraoxonase) Is Worse in Nondiabetic, Postmenopausal African American Than in White Women. Diabetes Care 2011;34:e19
por: Gaillard, Trudy, et al.
Publicado: (2011)

Vitamin K2 Supplementation Improves Insulin Sensitivity via Osteocalcin Metabolism: A Placebo-Controlled Trial
por: Choi, Hyung Jin, et al.
Publicado: (2011)

Comment on: Luijf et al. Premeal Injection of Rapid-Acting Insulin Reduces Postprandial Glycemic Excursions in Type 1 Diabetes. Diabetes Care 2010;33:2152–2155
por: Scaramuzza, Andrea E., et al.
Publicado: (2011)

Response to Comment on: Luijf et al. Premeal Injection of Rapid-Acting Insulin Reduces Postprandial Glycemic Excursions in Type 1 Diabetes. Diabetes Care 2010;33:2152–2155
por: Luijf, Yoeri M., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_6kmls7o38rtmt3vh5dp0gvnfc6